Literature DB >> 12714519

Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation.

Michael J Nemeth1, David J Curtis, Martha R Kirby, Lisa J Garrett-Beal, Nancy E Seidel, Amanda P Cline, David M Bodine.   

Abstract

Hmgb3 is a member of a family of chromatin-binding proteins that can alter DNA structure to facilitate transcription factor binding. We identified the Hmgb3 cDNA in a subtractive hybridization screen for transcripts that are preferentially expressed in hematopoietic stem cells. We inserted an internal ribosomal entry site-green fluorescence protein cassette into the 3' untranslated region of the X-linked Hmgb3 locus to identify Hmgb3-expressing cells. In adult mice, Hmgb3 mRNA is detected in bone marrow cells, primitive Lin-, c-kit+, Sca-1+, IL-7Ralpha- cells, and Ter119+ erythroid cells. We observed that long-term repopulating ability is entirely contained in the subpopulation of Lin-, c-kitHI cells that express Hmgb3. Most common lymphoid and myeloid progenitors express Hmgb3. Introduction of a retrovirus containing the Hmgb3 cDNA into mouse bone marrow stem cells demonstrated that enforced expression of Hmgb3 inhibited B-cell and myeloid differentiation. We conclude that down-regulation of Hmgb3 protein levels is an important step for myeloid and B-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12714519     DOI: 10.1182/blood-2002-11-3541

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation.

Authors:  Michael J Nemeth; Martha R Kirby; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

Review 2.  HMG chromosomal proteins in development and disease.

Authors:  Robert Hock; Takashi Furusawa; Tetsuya Ueda; Michael Bustin
Journal:  Trends Cell Biol       Date:  2006-12-13       Impact factor: 20.808

3.  Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation.

Authors:  Michael J Nemeth; Lilia Topol; Stacie M Anderson; Yingzi Yang; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

4.  MicroRNA-758 inhibits cervical cancer cell proliferation and metastasis by targeting HMGB3 through the WNT/β-catenin signaling pathway.

Authors:  Tao Song; Xinghua Hou; Bing Lin
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

Review 5.  HMGB proteins and arthritis.

Authors:  Noboru Taniguchi; Yasuhiko Kawakami; Ikuro Maruyama; Martin Lotz
Journal:  Hum Cell       Date:  2017-09-15       Impact factor: 4.174

6.  Knockdown of high mobility group box 3 impairs cell viability and colony formation but increases apoptosis in A549 human non-small cell lung cancer cells.

Authors:  Ning Song; Baohua Wang; Guishan Feng; Lin Duan; Shengfang Yuan; Weihua Jia; Yi Liu
Journal:  Oncol Lett       Date:  2019-01-14       Impact factor: 2.967

7.  A role for autophagic protein beclin 1 early in lymphocyte development.

Authors:  Ivica Arsov; Adeola Adebayo; Martina Kucerova-Levisohn; Joanna Haye; Margaret MacNeil; F Nina Papavasiliou; Zhenyu Yue; Benjamin D Ortiz
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

Review 8.  The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance.

Authors:  Bin Wen; Ying-Ting Wei; Kui Zhao
Journal:  Mol Cell Biochem       Date:  2021-01-11       Impact factor: 3.396

9.  Prognostic value of HMGB3 expression in patients with non-small cell lung cancer.

Authors:  Ning Song; Bao Liu; Jian-Ling Wu; Rui-Fang Zhang; Lin Duan; Wen-Shu He; Cong-Min Zhang
Journal:  Tumour Biol       Date:  2013-04-23

10.  Expression profiles during dedifferentiation in newt lens regeneration revealed by expressed sequence tags.

Authors:  Nobuyasu Maki; John Martinson; Osamu Nishimura; Hiroshi Tarui; Jaroslaw Meller; Panagiotis A Tsonis; Kiyokazu Agata
Journal:  Mol Vis       Date:  2010-01-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.